By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Vitae Pharmaceuticals, Inc. 

502 West Office Center Drive

Fort Washington  Pennsylvania  19034  U.S.A.
Phone: 215-461-2000 Fax: 215-461-2006


Company News
Vitae Pharmaceuticals, Inc. (VTAE) Reports Third Quarter 2014 Operating And Financial Results 11/13/2014 10:03:13 AM
Vitae Pharmaceuticals, Inc. (VTAE) To Present At Stifel 2014 Healthcare Conference 11/12/2014 10:28:11 AM
Vitae Pharmaceuticals, Inc. (VTAE) To Announce Third Quarter 2014 Financial Results On November 12, 2014 11/6/2014 10:49:02 AM
Vitae Pharmaceuticals, Inc. (VTAE) Announces Exercise Of Underwriters' Option To Purchase Additional Shares Of Initial Public Offering 10/28/2014 7:05:38 AM
Vitae Pharmaceuticals, Inc. (VTAE) Release: Positive Top-Line Results Achieved From Two Phase 1 Clinical Trials Of BACE Inhibitor BI1181181/VTP-37948 In Alzheimer's Disease 10/24/2014 7:39:38 AM
Vitae Pharmaceuticals, Inc. (VTAE) Announces Closing Of Initial Public Offering 9/29/2014 11:23:58 AM
Vitae Pharmaceuticals, Inc. (VTAE) Prices IPO At $8.00 A Share 9/24/2014 7:55:57 AM
Diabetes/Alzheimer's Biotech Vitae Pharmaceuticals, Inc. Sets Terms For $60 Million IPO 9/9/2014 6:51:25 AM
Vitae Pharmaceuticals, Inc. Adds To Leadership Team With Appointment Of Arthur Fratamico As Chief Business Officer, Richard Morris As Chief Financial Officer 7/8/2014 6:26:34 AM
Vitae Pharmaceuticals, Inc. Earns $14 Million Milestone Payment From Boehringer Ingelheim Corporation In Alzheimer's Collaboration 2/20/2014 7:02:42 AM